Related Experiment Video
Updated: May 6, 2026

08:08
An in vivo Rodent Model of Contraction-induced Injury and Non-invasive Monitoring of Recovery
Published on: May 11, 2011
14.0K
Metabolic and Structural Alterations in the Motor System Following Spinal Cord Injury: An In-Vivo 1H-MR Spectroscopy
Simon Schading-Sassenhausen1, Anna Lebret1, Kadir Şimşek2,3
1Spinal Cord Injury Center, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Journal of Neuroscience Research
|July 24, 2025
Summary
Spinal cord injury (SCI) causes widespread neuronal changes, indicated by reduced N-acetylaspartate in the motor cortex and lumbar cord. These metabolic and structural alterations highlight neurodegeneration and inform future SCI treatments.
Area of Science:
- Neuroscience
- Radiology
- Biomarkers
Background:
- Spinal cord injury (SCI) disrupts neural pathways critical for motor control.
- Understanding the metabolic and structural consequences of SCI is crucial for developing effective treatments.
Purpose of the Study:
- To investigate metabolite concentration differences in the primary motor cortex (M1) and lumbar cord enlargement (LCE) between SCI patients and healthy controls (HC).
- To correlate metabolic and structural changes with clinical impairment in chronic SCI.
Main Methods:
- Proton magnetic resonance spectroscopy (1H-MRS) was used to quantify metabolites in M1 and LCE.
- Structural MRI (T1- and T2*-weighted) assessed tissue atrophy.
- Associations between metabolic, structural changes, and clinical impairment were analyzed.
Main Results:
- Significant white matter and gray matter atrophy was observed in the LCE of SCI patients compared to HCs.
- Reduced total N-acetylaspartate to total creatine ratio (tNAA/tCr) was found in the M1 and LCE of SCI patients.
- These metabolic changes correlated with observed atrophy and neurodegeneration.
Conclusions:
- Reduced tNAA/tCr in atrophied M1 and LCE suggests widespread neuronal damage, including cell atrophy and loss, following SCI.
- Findings provide in vivo evidence for retrograde and trans-synaptic neurodegeneration in SCI.
- Metabolic and structural biomarkers show potential for monitoring neurodegeneration and guiding regenerative strategies in SCI.

